Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathological gambling.

E Hollander1, A J Buchalter, C M DeCaria

  • 1Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA.

The Psychiatric Clinics of North America
|September 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing first line treatments for adults with OCD.

Comprehensive psychiatry·2022
Same author

Obsessive-compulsive disorder during the COVID-19 pandemic.

Journal of psychiatric research·2022
Same author

Potential of cannabinoids as treatments for autism spectrum disorders.

Journal of psychiatric research·2021
Same author

The Future of Obsessive-Compulsive Spectrum Disorders: A Research Perspective.

Current topics in behavioral neurosciences·2021
Same author

How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology.

Comprehensive psychiatry·2020
Same author

Rapid atrial fibrillation, rapid cardioversion, rapid return home.

Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias·2019

Pathological gambling (PG) is a growing mental health issue impacting individuals and society. Research is exploring its neurobiology and effective treatments like medications and cognitive-behavioral therapy to aid recovery.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Mental Health

Background:

  • Pathological gambling (PG) is an emerging impulse-control disorder with increasing prevalence.
  • PG is often comorbid with other mental health conditions and linked to severe personal, financial, and legal consequences, including high suicide rates.
  • The neurobiology of PG is under investigation, with neurotransmitters like serotonin (5-HT), norepinephrine, and dopamine implicated in its development and maintenance.

Purpose of the Study:

  • To review the current understanding of pathological gambling's neurobiology.
  • To discuss emerging pharmacological and psychotherapeutic treatment strategies for PG.
  • To highlight the need for further research in risk identification, prevention, and funding for PG initiatives.

Main Methods:

Related Experiment Videos

  • Literature review of neurobiological underpinnings of PG.
  • Summary of current and potential pharmacologic treatments (e.g., SRIs, mood stabilizers, naltrexone).
  • Overview of cognitive-behavioral psychotherapies as a treatment modality.

    • Main Results:

    • Serotonin (5-HT) is linked to behavioral initiation and disinhibition in gambling.
    • Norepinephrine is associated with arousal and risk-taking behaviors in PG.
    • Dopamine plays a role in the reward pathways, contributing to the addictive nature of PG.

    Conclusions:

    • Effective treatments for PG are emerging, including pharmacologic agents and cognitive-behavioral therapies.
    • Further research is crucial to identify at-risk individuals for prevention and early intervention programs.
    • Dedicated funding, potentially from gambling revenues, is needed for specialized treatment, education, and research into PG.